US open: Tech stocks rebound ahead of Powell's testimony

Tech stocks lead the move higher on Wall Street as Fed fears ease ahead of Powell's testimony.

USA (2)

US futures

Dow futures +0.06% at 36086

S&P futures +0.1% at 4677

Nasdaq futures +0.18% at 15643

In Europe

FTSE +0.38% at 7485

Dax +0.85% at 15938

Euro Stoxx +0.95% at 4280

Learn more about trading indices

High growth back in favour

US stocks are set to open higher with the Nasdaq set to lead Wall Street higher as investors await Fed Chair Powell’s testimony later in the session. The Senate Confirmation hearing for Powell’s second term could see the head of the US central bank provide more information on potential rate hikes.

The pre-released statement how not provided any new information on policy. However, the Q&A session could provide more insight. Powell is expected to be grilled over the Fed’s plans to prevent high inflation from becoming entrenched.

Goldman Sachs have said that they expect 4 rate hikes from the Fed this year. JP Morgan have said the same.

Tech stocks are set to outperform after a tough start to 2022. Tech has been out of favour amid a rotation into tech as treasury yields surged. However, Fed fears are easing today, 10 year treasury yields are falling and bargain hunters appear to be out taking advantage of the recent tumble in high growth shares, lifting the Nasdaq.

In corporate news:

Tesla trades higher pre-market after reporting 70,847 China made vehicle sales in December. This was the highest monthly rate since it started manufacturing in Shanghai in 2019.

Rivian trades 4.1% lower pre-market after reports that its head of operations Rod Copes left the EV maker last month.


Where next for the Nasdaq?

The Nasdaq is moving higher from the 15165 low howver is stalling around the 100 sma. With the RSI favouring further downside, the move higher could be seen as a selling opportunity. Failure to break cleanly above the 100 sma could see sellers push the price back towards 15165. A move above the 50 sma at 16168 could negate the near term bear trend. 

Nasdaq chart

FX markets steady ahead of Powell

The USD is holding steady as the FX markets remain calm ahead of Fed Chair Powell’s testimony before Congress later today. The prepared statement offers no new fresh policy insight. Any sense of a more hawkish position could boost the USD.

EUR/USD trades quietly around 1.1340 even after the new head of the Bundesbank Joachin Nagel is sworn in and changed the German central bank’s stance on inflation, saying that it was not entirely temporary. This was is stark comparison to ECB President Christine Lagarde who has stuck with the transitory script, down playing inflation risks.

GBP/USD +0.04% at 1.3578

EUR/USD +0.04% at 1.1330


Oil rises towards $80 as demand remains solid

Oil prices are on the rise boosted by a combination of tight supply and optimism that the spread of Omicron won’t derail the global economic recovery and oil demand.

Developed economies are not imposing tighter lockdown restrictions to cope with Omicron, keeping the demand outlook steady. Simultaneously OPEC+ countries are failing to reach their demand output following the increase. In other words, they are running below the allowed increase, mainly due to lack of capacity, whilst demand remains buoyant.

API crude oil stock pile data is due to be released.

WTI crude trades +1.5% at $78.84

Brent trades +1.3% at $81.67

Learn more about trading oil here.


Looking ahead

15:00 Fed Chair Powell speech

21:30 API weekly crude oil stockpiles

How to trade with City Index


Follow these easy steps to start trading with City Index today:

  1. Open a City Index account, or log-in if you’re already a customer.
  2. Search for the market you want to trade in our award-winning platform.
  3. Choose your position and size, and your stop and limit levels
  4. Place the trade.







This report is intended for general circulation only. It should not be construed as a recommendation, or an offer (or solicitation of an offer) to buy or sell any financial products. The information provided does not take into account your specific investment objectives, financial situation or particular needs. Before you act on any recommendation that may be contained in this report, independent advice ought to be sought from a financial adviser regarding the suitability of the investment product, taking into account your specific investment objectives, financial situation or particular needs.

StoneX Financial Pte. Ltd., may distribute reports produced by its respective foreign entities or affiliates within the StoneX group of companies or third parties pursuant to an arrangement under Regulation 32C of the Financial Advisers Regulations. Where the report is distributed to a person in Singapore who is not an accredited investor, expert investor or an institutional investor (as defined in the Securities Futures Act), StoneX Financial Pte. Ltd. accepts legal responsibility to such persons for the contents of the report only to the extent required by law. Singapore recipients should contact StoneX Financial Pte. Ltd. at 6826 9988 for matters arising from, or in connection with the report.

In the case of all other recipients of this report, to the extent permitted by applicable laws and regulations neither StoneX Financial Pte. Ltd. nor its associated companies will be responsible or liable for any loss or damage incurred arising out of, or in connection with, any use of the information contained in this report and all such liability is hereby expressly disclaimed. No representation or warranty is made, express or implied, that the content of this report is complete or accurate.

StoneX Financial Pte. Ltd. is not under any obligation to update this report.

Trading CFDs and FX on margin carries a high level of risk that may not be suitable for some investors. Consider your investment objectives, level of experience, financial resources, risk appetite and other relevant circumstances carefully. The possibility exists that you could lose some or all of your investments, including your initial deposits. If in doubt, please seek independent expert advice. Visit for the complete Risk Disclosure Statement.